Top

Health and Quality of Life Outcomes

Published in:

Open Access 01-12-2007 | Research

Examining correlates of treatment satisfaction for injectable insulin in type 2 diabetes: lessons learned from a clinical trial comparing biphasic and basal analogues

Authors: Meryl Brod, David Cobden, Morten Lammert, Donald Bushnell, Philip Raskin

Published in: Health and Quality of Life Outcomes | Issue 1/2007

Abstract

Background

Successfully managing diabetes is a complex process that includes addressing issues of drug efficacy, safety and treatment satisfaction. Additionally, the combined impact of patient/disease characteristics and treatment outcomes on treatment satisfaction is not well understood. The purpose of this study was to examine the impact of age, weight, gender, co-morbid conditions, diabetes history, treatment burden, efficacy (HbA_1c) and side effects (weight gain, hypoglycemic events) on patients' appraisal of treatment satisfaction using linear regression models.

Methods

Data from a multi-center, randomized clinical trial comparing the efficacy/safety of biphasic insulin aspart 70/30 (BIAsp 70/30) vs. glargine (Glar) among insulin naïve type 2 patients were analyzed. Subjects were between ages 18–75, with baseline HbA_1c > 8% and BMI ≤ 40 kg/m² (N = 233). Treatment satisfaction was assessed by the Insulin Treatment Satisfaction Questionnaire (ITSQ).

Results

When factors were examined independently, multiple significant relationships (age, co-morbidity, hypoglycemic events, and weight gain) with overall and/or domains of treatment satisfaction were found. However, when all significant relationships were examined together, only neuropathy, treatment efficacy, and number of hypoglycemic events maintained their previous significance.

Conclusion

By examining predictors independently, significant relationships were identified. However, not all findings remained significant when examined in combination with each other. Thus, to more accurately characterize the impact of factors on treatment satisfaction, a more comprehensive approach may be necessary. By improving patient treatment satisfaction, the efficacy of treatments, as well as critical treatment outcomes such as compliance and cost of care should be improved.

Weaver M, Patrick DL, Markson LE, Martin D, Frederic I, Berger M: Issues in the measurement of satisfaction with treatment. Am J Man Care 1997, 3: 579–594.

Albrecht G, Hoogstraten J: Satisfaction as determination of compliance. Community Dent Oral Epidemiol 1998, 26: 139–146. 10.1111/j.1600-0528.1998.tb01940.xPubMedCrossRef

Atkinson MJ, Kumar R, Cappelleri JC, Hass SL: Hierarchical construct validity of the treatment Satisfaction Questionnaire for Medication (TSQM Version ll) among outpatient pharmacy consumers. Value Health 2005, 8: S9-S24. 10.1111/j.1524-4733.2005.00066.xPubMedCrossRef

Menzin J, Langley-Hawthorne C, Friedman M, Boulanger L, Cavanaugh R: Potential short-term economic benefits of improved glycemic control: a managed care perspective. Diabetes Care 2001, 24: 51–55.PubMedCrossRef

Hogan P, Dall T, Nikolov P, American Diabetes Association: Economic Costs of Diabetes in the U.S. in 2002. Diabetes Care 2003, 26: 917–932.PubMedCrossRef

Anderson RT, Marrero D, Skovlund SE, Cramer J, Schwartz S: Self-reported compliance with insulin injection therapy in subjects with type 1 and 2 diabetes. Diabetologia 2003, 46: A275. 10.1007/s00125-003-1112-xCrossRef

Rosenstock J, Cappelleri JC, Bolinder B, Gerber RA: Patient satisfaction and glycemic control after 1 year with inhaled insulin (Exubera) in patients with type 1 or type 2 diabetes. Diabetes Care 2004, 27: 1318–1323.PubMedCrossRef

Clark CM Jr, Snyder JW, Meek RL, Stutz LM, Parkin CG: A systematic approach to risk stratification and intervention within a managed care environment improves diabetes outcomes and patient satisfaction. Diabetes Care 2001, 24: 1079–1086.PubMedCrossRef

Colman SS, Brod MI, Krishnamurthy A, Rowland CR, Jirgens KJ, Gomez-Mancilla B: Treatment satisfaction, functional status and health related quality of life of patients with migraine randomly assigned to almotriptan or aumatriptan. Clin Ther 2001, 23: 127–145. 10.1016/S0149-2918(01)80036-9PubMedCrossRef

10.

Weijman I, Ros WJ, Rutten GE, Schaufeli WB, Schabracq MJ, Winnubst JA: Frequency and perceived burden of diabetes self-management activities in employees with insulin-treated diabetes: relationships with health outcomes. Diabetes Res Clin Pract 2005, 68: 56–64. 10.1016/j.diabres.2004.08.004PubMedCrossRef

11.

Anderson RT, Skovlund SE, Marrero D, Levine DW, Meadows K, Brod M, Balkrishnan R: Development and validation of the insulin treatment satisfaction questionnaire. Clin Ther 2004, 26: 565–578. 10.1016/S0149-2918(04)90059-8PubMedCrossRef

12.

Testa M: Improving diabetes therapy: improving satisfaction. Diabetes Voice 2003, 48: 23–25.

13.

Brod M, Skovlund SE, Wittrup-Jensen KU: Measuring the impact of diabetes through patient report of treatment satisfaction, productivity and symptom experience. Qual Life Res 2006, 15: 481–491. 10.1007/s11136-005-1624-6PubMedCrossRef

14.

Atkinson MJ, Sinha A, Hass SL, Colman SS, Kumar RN, Brod M, Rowland CR: Validation of a general measure of treatment satisfaction, the Treatment Satisfaction Questionnaire for Medication (TSQM), using a national panel study of chronic disease. Health Qual Life Outcomes 2004, 2: 12. 10.1186/1477-7525-2-12PubMedCentralPubMedCrossRef

15.

Greenfield S, Kaplan SH, Kahn R, Ninomiya J, Griffith JL: Profiling care provided by different groups of physicians: effects of patient case-mix (bias) and physician-level clustering on quality assessment results. Ann Intern Med 2002, 136: 111–121.PubMedCrossRef

16.

Cappelleri JC, Gerber RA, Kourides IA, Gelfand RA: Development and factor analysis of a questionnaire to measure patient satisfaction with injected and inhaled insulin for type 1 diabetes. Diabetes Care 2000, 23: 1799–1803.PubMedCrossRef

17.

Redekop WK, Koopmanschap MA, Stolk RP, Rutten GE, Wolffenbuttel BH, Niessen LW: Health-related quality of life and treatment satisfaction in Dutch patients with Type 2 diabetes. Diabetes Care 2002, 25: 458–463.PubMedCrossRef

18.

Taylor MD, Frier BM, Gold AE, Deary IJ, Edinburgh Prospective Diabetes Study: Psychosocial factors and diabetes-related outcomes following diagnosis of type 1 diabetes in adults: the Edinburgh prospective diabetes study. Diabet Med 2003, 20: 135–146. 10.1046/j.1464-5491.2003.00887.x

19.

Petterson T, Lee P, Hollis S, Young B, Newton P, Dornan T: Well-being and treatment satisfaction in older people with diabetes. Diabetes Care 1998, 21: 930–935.PubMedCrossRef

20.

Bech P, Moses R, Gomis R: The effect of prandial glucose regulation with repaglinide on treatment satisfaction, wellbeing and health status in patients with pharmacotherapy naive Type 2 diabetes: a placebo-controlled, multicentre study. Qual Life Res 2003, 12: 413–425. 10.1023/A:1023495106160PubMedCrossRef

21.

Herman WH, Ilag LL, Johnson SJ, Martin CL, Sinding J, Al Harthi A, Plunkett CD, LaPorte FB, Burke R, Brown MB, Halter JB, Raskin P: A clinical trial of continuous subcutaneous insulin infusion versus multiple daily injections in older adults with type 2 diabetes. Diabetes Care 2005, 28: 1568–1573.PubMedCrossRef

22.

Wilson M, Moore MP, Lunt H: Treatment satisfaction after commencement of insulin in Type 2 diabetes. Diabetes Res Clin Pract 2004, 66: 263–267. 10.1016/j.diabres.2004.04.010PubMedCrossRef

23.

Brod M, Lammert M, Raskin P: Comparison of treatment satisfaction of twice-daily BIAsp 70/30 with once-daily insulin glargine in patients with type 2 diabetes. Poster presented at the 65th Scientific Session of the American Diabetes Association Meeting – San Diego, California, 2005. of the American Diabetes Association Meeting – San Diego, California 2005.

24.

Bradley C, Plewe G, Kliebe-Frisch : Treatment satisfaction with a basal insulin added to oral agents versus twice-daily premixed insulin alone in patients with Type 2 diabetes. Diabetes 2005, 54: A304.

25.

Raskin P, Bode PW, Marks JB, Hirsch IB, Weinstein RL, McGill JB, Peterson GE, Mudaliar SR, Reinhardt RR: Continuous subcutaneious insulin infusion and multiple daily injection therapy are equally effective in type 2 diabetes: a randomized, parallel-group, 24 week study. Diabetes Care 2003, 26: 2598–2603.PubMedCrossRef

26.

Hoogma RP, Spijker AJ, van Doorn-Scheele M, van Doorn TT, Michels RP, van Doorn RG, Levi M, Hoekstra JB: Quality of Life and metabolic control in patients with diabetes mellitus type 1 treated by continuous subcutaneous insulin infusion of multiple daily insulin injections. Neth J Med 2004, 62: 383–387.PubMed

27.

Raskin P, Allen E, Hollander P, Lewin A, Gabbay RA, Hu P, Bode B, Garber A, INITIATE Study Group: Initiating insulin therapy in type 2 diabetes. Diabetes Care 2005, 28: 260–265.PubMedCrossRef

28.

Korytkowski M, Bell D, Jacobsen C, Suwannasari R, FlexPen Study Team: A multicenter, randomized open-label comparative, two-period crossover trial of preference, efficacy, and safety profiles of a prefilled, disposable pen and conventional vial/syringe for insulin injection in patients with type 1 or 2 diabetes mellitus. Clin Ther 2003, 25: 2836–2848. 10.1016/S0149-2918(03)80337-5PubMedCrossRef

29.

Rubin RR, Peyrot M: Quality of life, treatment satisfaction and treatment preference associated with use of a pen device delivering a pemixed 70/30 insulin aspart suspension (aspart protamine suspension/soluble aspart) versus alternative treatment strategies. Diabetes Care 2004, 27: 2495–2497.PubMedCrossRef

30.

Summers KH, Szeinbach SL, Lenox SM: Preference for insulin delivery systems among current users and nonusers. Clin Ther 2004, 26: 1498–1505. 10.1016/j.clinthera.2004.09.009PubMedCrossRef

31.

Peyrot M, Rubin RR, Lauritzen T, Skovlund SE, Snoek FJ, Matthews DR, Landgraf R, Kleinebreil L, The International DAWN Advisory Panel: Resistance to insulin therapy among patients and providers: results of the cross-national Diabetes Attitudes, Wishes, and Needs (DAWN) study. Diabetes Care 2005, 28: 2673–2679.PubMedCrossRef

32.

Garber AJ, Wahlen J, Wahl T, Bressler P, Braceras R, Allen E, Jain R: Attainment of glycaemic goals in type 2 diabetes with once-twice, or thrice-daily dosing with biphasic insulin aspart 70/30 (The 1–2-3 study). Diabetes Obes Metab 2006, 8: 58–66. 10.1111/j.1463-1326.2005.00563.xPubMedCrossRef

33.

Kann P, Wascher T, Zackova V, Moeller J, Medding J, Szocs A, Mokan M, Mrevlje F, Regulshki M: Starting insulin therapy in type 2 diabetes: twice-daily biphasic insulin Aspart 30 plus metformin versus once-daily insulin glargine plus glimepiride. Exp Clin Endocrinol Diabetes 2006,114(9):527–32. 10.1055/s-2006-949655PubMedCrossRef

34.

Goudswaard AN, Stolk RP, Zuithoff P, de Valk HW, Rutten GE: Starting insulin in type 2 diabetes: continue oral hypoglycemic agents? A randomized trial in primary care. The J Fam Pract 2004, 53: 393–399.PubMed

35.

Shaw WS, Zaia A, Pransky G, Winters T, Patterson WB: Perceptions of provider communication and patient satisfaction for treatment of acute low back pain. J Occup Environ Med 2005, 47: 1036–1043. 10.1097/01.jom.0000172863.26222.14PubMedCrossRef

36.

Hirsh AT, Atchison JW, Berger JJ, Waxenberg LB, Lafayette-Lucey A, Bulcourf BB, Robinson ME: Patient satisfaction with treatment for chronic pain: predictors and relationship to compliance. Clin J Pain 2005, 21: 302–310. 10.1097/01.ajp.0000113057.92184.90PubMedCrossRef

37.

McCracken LM, Klock PA, Mingay DJ, Asbury JK, Sinclair DM: Assessment of satisfaction with treatment for chronic pain. J Pain Symptom Manage 1997, 14: 292–299. 10.1016/S0885-3924(97)00225-XPubMedCrossRef

38.

Niskanen L, Jensen EJ, Rastam J, Nygaard-Pedersen L, Erichsen K, Vora JP: Randomized, multinational open-label, 2-period, crossover comparison of biphasic insulin aspart 30 and biphasic insulin lispor 25 and pen devices in adult patients with Type 2 diabetes mellitus. Clin Ther 2004, 26: 531–540. 10.1016/S0149-2918(04)90055-0PubMedCrossRef

39.

Asakura T, Seino H: Assessment of dose selection attributes with audible notification in insulin pen devices. Diabetes Technol Ther 2005, 7: 620–626. 10.1089/dia.2005.7.620PubMedCrossRef

40.

Ray JA, Valentine J, Nicklasson L, Cobden D, Raskin P, Garber A, Palmer AJ: Insulin therapy in type 2 diabetes patients failing oral agents: cost-effectiveness of biphaic insulin aspart 70/30 vs. insulin glargine in the US. Diabetes Obes Metab 2007, 9: 103–113. 10.1111/j.1463-1326.2006.00581.xPubMedCrossRef

41.

Valentine WJ, Palmer AJ, Lammert M, Nicklasson L, Foos V, Roze S: Long-term clinical and cost outcomes of treatment with biphasic insulin aspart 30/70 versus insulin glargine in insulin naive type 2 diabetes patients: cost-effectiveness analysis in the UK setting. Curr Med Res Opin 2005, 21: 2063–2071. 10.1185/030079905X74989PubMedCrossRef

42.

Hurwitz EL, Morgenstern , Yu F: Satisfaction as a predictor of clinical outcomes among chiropractic and medical patients enrolled in the UCLA low back pain study. Spine 2005, 30: 2121–2128. 10.1097/01.brs.0000180639.67008.d0PubMedCrossRef

Title: Examining correlates of treatment satisfaction for injectable insulin in type 2 diabetes: lessons learned from a clinical trial comparing biphasic and basal analogues
Authors: Meryl Brod
David Cobden
Morten Lammert
Donald Bushnell
Philip Raskin
Publication date: 01-12-2007
Publisher: BioMed Central
Published in: Health and Quality of Life Outcomes / Issue 1/2007
Electronic ISSN: 1477-7525
DOI: https://doi.org/10.1186/1477-7525-5-8

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Examining correlates of treatment satisfaction for injectable insulin in type 2 diabetes: lessons learned from a clinical trial comparing biphasic and basal analogues

Abstract

Background

Methods

Results

Conclusion

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Background

Methods

Results

Conclusion

Please log in to get access to this content

Other articles of this Issue 1/2007

Effects of risk-based multifactorial fall prevention on health-related quality of life among the community-dwelling aged: a randomized controlled trial

Health-related quality of life of patients following selected types of lumbar spinal surgery: A pilot study

A longitudinal evaluation of the Center for Epidemiologic Studies-Depression scale (CES-D) in a Rheumatoid Arthritis Population using Rasch Analysis

The Warwick-Edinburgh Mental Well-being Scale (WEMWBS): development and UK validation

Applicability of an abbreviated version of the Child-OIDP inventory among primary schoolchildren in Tanzania

The effect of co-morbidities on health-related quality of life in patients placed on the waiting list for total joint replacement